Salisbury Foundation Trust

FOI_5602

Internal Reference Number: FOI_5602

Date Request Received: 09/03/2020 15:43:45

Date Request Replied To: 17/04/2020 10:47:24

This response was sent via: By Email

Request Summary: Cannabis-Based Products for Medicinal Use

Request Category: Companies

 
Question Number 1:
Since 1 November 2018, how many applications regarding unlicensed Cannabis-Based Products for Medicinal Use (CBPMs) have been received by your Drug and Therapeutic Committee, or a similar clinical governance body? Please exclude Sativex and Epidiolex.
a. Please provide the therapeutic indication for the applications received e.g. chronic pain
b. Please detail from which department the request originated?
 
Answer To Question 1:
Nil
 
Question Number 2:
Of the total number of applications to your Drug and Therapeutic Committee, or a similar clinical governance body, how many applications for unlicensed CBPMs has the Trust declined since 1 November 2018? Please provide any details as to the reason/s behind declining the applications.
 
Answer To Question 2:
N/A
 
Question Number 3:
Of the total number of applications to your Drug and Therapeutic Committee, or a similar clinical governance body, how many applications for unlicensed CBPMs has the Trust accepted since 1 November 2018? Please provide any details of the application accepted where possible, including the cost of reimbursement and the product/s prescribed.
a. Please provide the therapeutic indication for the applications received e.g. chronic pain
b. Please detail from which department the request originated?
 
Answer To Question 3:
N/A
 
Question Number 4:
For applications to your Drug and Therapeutic Committee, or a similar clinical governance body, that have been accepted, please advise what the subsequent stage was (if there was one)? E.g. an Individual Funding Request being submitted or new entries being added to the Trust Formulary.
 
Answer To Question 4:
N/A
 
Question Number 5:
Please clarify whether funding for unlicensed Cannabis-Based Products for Medicinal Use is at CCG or Trust level?
 
Answer To Question 5:
Our CCG does not currently fund Cannabis based products so any expenditure would remain at Trust level
 
Question Number 6:
Please clarify whether your Trust operates a policy with a capped number of prescriptions or duration of prescriptions for unlicensed Cannabis-Based Products for Medicinal Use?
 
Answer To Question 6:
No
 
To return to the list of all the FOI requests please click here

Our staff at Salisbury District Hospital have long been well regarded for the quality of care and treatment they provide for our patients and for their innovation, commitment and professionalism. This has been recognised in a wide range of achievements and it is reflected in our award of NHS Foundation Trust status. This is afforded to hospitals that provide the highest standards of care.

Salisbury NHS Foundation Trust, Salisbury District Hospital, Salisbury, Wiltshire, SP2 8BJ
T: 01722 336262 E: sft.pals@nhs.net
© 2021 Salisbury NHS Foundation Trust
Trust Values